P&T
Our
Other
Journal
MediMedia Managed Markets
Managed Care

 

Ulcerative Colitis: The Value of Persistence in Therapy

Ulcerative Colitis: The Value of Persistence in Therapy

This Brief reviews a potential treatment option for patients with ulcerative colitis. This chronic inflammatory disease may significantly affect a person’s health and quality of life. A once-daily oral medication, MMX mesalamine, may be beneficial to these patients by limiting pill burden and potentially increasingly the likelihood of medication compliance.

Highlights:

  • Discussion of the incidence and prevalence of ulcerative colitis, along with its socioeconomic impact
  • Overview of the available treatment modalities, with a focus on 5-aminosalicylate therapy
  • Review of two pivotal trials that examined the efficacy of MMX mesalamine for patients with mild-to-moderative ulcerative colitis